Urinary urgency

Reading File
Finding Sources
Finding Sources
Searching PubMed

"urinary urgency" AND "overactive bladder"

Reading File
Reading File
Reading File
Reading File
Reading File
I now have thorough content from Campbell-Walsh Urology and Smith & Tanagho. Let me compile a comprehensive answer.

Urinary Urgency

Definition

Urinary urgency is defined by the International Continence Society (ICS) as "a sudden compelling desire to pass urine, which is difficult to defer." While some degree of urge to void is normal when the bladder has been held for a prolonged time, pathological urgency should not occur under ordinary circumstances.
  • Campbell-Walsh Wein Urology: "Urinary urgency indicates difficulty in postponing urination... it should not occur otherwise."
  • Smith & Tanagho's General Urology (19th ed.): Urgency is a lower urinary tract storage symptom distinct from the normal physiological sensation of bladder fullness ("urge").

Overactive Bladder (OAB) - The Core Syndrome

Urgency is the hallmark symptom of Overactive Bladder (OAB):
OAB = Urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence (UUI), in the absence of UTI or other obvious pathology.
  • OAB "wet" - urgency + urge incontinence (involuntary urine loss associated with urgency)
  • OAB "dry" - urgency without incontinence

Pathophysiology

Urgency/OAB can arise from dysfunction at three levels:
OriginMechanism
NeurogenicBrain/spinal cord lesions removing inhibitory control (e.g., stroke, MS, Parkinson's, spinal cord injury above sacrum)
MyogenicDetrusor smooth muscle instability or low bladder compliance
UrothelialAbnormal afferent signaling from urothelium (e.g., interstitial cystitis, inflammation)
Common underlying causes include: neuropathic injury, bladder outlet obstruction (BPH), UTI/cystitis, bladder stones, diabetes mellitus, interstitial cystitis, and radiation cystitis.
The basic urodynamic finding is detrusor overactivity (DO) - involuntary detrusor contractions during filling. Note: up to 50% of OAB patients may not show DO on urodynamics on any given study, so clinical context matters.

Differential Diagnosis of Urgency

CauseKey Features
OAB (idiopathic)Frequency, nocturia, no infection
UTI/cystitisDysuria, pyuria, bacteriuria
Bladder stonesHematuria, pain
Bladder cancerHematuria, especially in >50 yr smokers
Interstitial cystitis/BPSSevere pelvic/bladder pain, frequency, no infection
BPH (men)Obstructive + irritative LUTS, weak stream
Neurogenic bladderNeurological history, examination signs
Radiation cystitisHistory of pelvic radiation
Important: In patients >50 years with a smoking history, irritative voiding symptoms (urgency, frequency, dysuria) can be the only presenting sign of bladder cancer - this mandates urological evaluation.

Evaluation

  1. History - onset, frequency, nocturia, incontinence, hematuria, neurological symptoms, pelvic surgery/radiation, medications
  2. Bladder diary (48 hours) - volumes voided, fluid intake, urgency episodes, incontinence - reveals functional capacity (~300-400 mL normal adult), polyuria, nocturia patterns
  3. Urinalysis + urine culture - exclude UTI, hematuria
  4. Post-void residual (PVR) - exclude incomplete emptying
  5. Urodynamics (UDS) - reserved for: diagnosis in doubt, failed initial therapy, suspected neurogenic bladder, coexisting BOO, significant PVR, or pre-surgical workup
  6. Cystoscopy - if hematuria, refractory symptoms, or suspected malignancy

Treatment - Stepwise Approach

Step 1: Conservative / Behavioral (6-12 weeks minimum)

  • Fluid management - reduce intake by ~25% if drinking >1 L/day; avoid caffeine, alcohol, carbonated drinks
  • Bladder training - gradually increase voiding intervals; teaches suppression of urgency
  • Pelvic floor muscle training (PFMT) - urgency suppression with voluntary pelvic floor contraction
  • Bowel management (constipation worsens OAB)
  • Weight loss, smoking cessation

Step 2: Pharmacotherapy

Antimuscarinics (9 agents with Grade A evidence, Level 1):
DrugNotes
OxybutyninAvailable oral, patch, topical gel; most side effects
TolterodineWidely used; extended-release preferred
SolifenacinBetter efficacy than tolterodine; less dry mouth
FesoterodineBetter efficacy vs. tolterodine; higher discontinuation
DarifenacinM3-selective; less CNS effects
Trospium chlorideQuaternary amine; minimal BBB crossing; less cognitive effect
PropiverineAvailable in some countries
  • Extended-release formulations preferred over immediate-release for tolerability
  • Main side effects: dry mouth, constipation, blurred vision, cognitive effects (especially in elderly)
Beta-3 agonist:
  • Mirabegron - relaxes detrusor via β₃ receptors; proven superiority to tolterodine for incontinence episodes and frequency; less dry mouth/constipation than antimuscarinics; side effects include palpitations and hypertension
  • Combination therapy (mirabegron 50 mg + solifenacin 5 mg) is superior to dose escalation of solifenacin alone, with better efficacy and fewer side effects (Drake et al., 2016)

Step 3: Minimally Invasive Procedures

  • OnabotulinumtoxinA (Botox) intravesical injection - reduces detrusor overactivity; effective for refractory OAB and neurogenic detrusor overactivity; risk of urinary retention (patient should be able to self-catheterize)
  • Sacral nerve modulation (SNM/InterStim) - implanted neuromodulation; used for refractory OAB and UUI
  • Posterior tibial nerve stimulation (PTNS) - percutaneous or transcutaneous; less invasive neuromodulation option

Step 4: Surgical (rarely needed)

  • Bladder augmentation cystoplasty - increases capacity; significant morbidity; for severe refractory cases
  • Urinary diversion (e.g., ileal conduit) - last resort

Special Populations

  • Neurogenic bladder - urgency with DO is the most common pattern in lesions above the brainstem or above the sacral cord; DESD (detrusor-external sphincter dyssynergia) may coexist in suprasacral lesions; antimuscarinics used; Botox has strong evidence
  • Elderly - antimuscarinics carry cognitive risk; prefer trospium, darifenacin, or mirabegron; assess fall risk
  • Women - estrogen deficiency contributes to urgency; topical vaginal estrogen may help (not systemic)
  • BPH (men) - combination alpha-blocker + antimuscarinic or mirabegron for mixed LUTS

Key Points

  • Urgency = sudden compelling desire to void, difficult to defer
  • OAB = urgency ± frequency, nocturia, ± incontinence; no infection
  • Always rule out UTI, hematuria, neurological cause
  • First-line: behavioral therapy (bladder training, PFMT, fluid management)
  • Second-line: antimuscarinics or mirabegron (Grade A evidence)
  • Refractory: Botox injection or sacral neuromodulation
  • Hematuria + urgency in a smoker >50 years = cystoscopy mandatory
Sources: Campbell-Walsh Wein Urology (10th ed.); Smith & Tanagho's General Urology (19th ed.); Bradley & Daroff's Neurology in Clinical Practice
This is a shared conversation. Sign in to Orris to start your own chat.